When Your Own Cells Become the Treatment For decades, cancer treatment has largely focused on using medicines to...
TMLabs Blogs
Talking Medicines Launches New DrugVoice Application Connecting Message Resonance with Intent-to-Prescribe
DrugVoice connects Talking Medicines’ Message Resonance Score™ with near-real-time point-of-care intent signals to...
From GLP-1s to the Next Generation of Peptides: Is Medicine Entering a Peptide Era?
From one blockbuster class to a new peptide paradigm GLP-1 receptor agonists have demonstrated that peptide medicines...
Branded or Compounded? What GLP-1 Consumers Are Really Asking
Consumers Are Looking Beyond the Brand Authorized, or branded, GLP-1 medicines are generally associated with...
GLP-1 Discontinuation: What Online Consumer Conversations Reveal About Long-Term Obesity Management
GLP-1 Discontinuation: Consumers Are Changing Conversation Healthcare has entered a new era where consumers are no...
From Dose Adjustments to Emotional Responses: What Consumers Are Saying About GLP-1 Weight Loss Plateaus
The Emergence of Informed Consumerization People begin their treatment journey as Patients, but their online behavior...
AI Agents Are the Orchestra, Not the Instruments: Why Domain Intelligence Still Matters in Life Sciences
The Rise of Agentic AI AI is entering a new era. Rather than simply responding to prompts, AI agents can...
Beyond LLMs: How Talking Medicines Defines an Agentic AI Architecture for Life Sciences
AI is Moving Beyond Standalone Models Much of the conversation around artificial intelligence still treats Large...
The Rise of the Metabolic Healthcare Consumer
From Weight Loss to Liver Health: What Consumer Conversations Reveal About the Emerging MASH Landscape Conversations...
Building Better Care Pathways with Patient Journey Intelligence
Care Pathways and Patient Journeys: What's the Difference? A care pathway describes the recommended route through...
How Evidence-Based Care Pathways Improve Patient Outcomes
The Role of Care Pathways in Modern Healthcare Care pathways provide structured, evidence-based guidance that...
Understanding GLP-1 Therapies: FDA-Approved Treatments, Compounded Medications, and Nutritional Support
GLP-1 Therapies: Targeting Metabolic Disease GLP-1 receptor agonists are prescription medicines designed to mimic...












